Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 17, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - August 17, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 112     Next >>     Go To Page:

8/10/17 - HEALTH & SUPPORT
Monday evenings at 63 Jefferson Ave., Salem; and from noon to 1:30 p.m. Fridays at 75 Lindall St., Danvers. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors' conference room at Beverly Hospital, 85 Herrick St., Beverly. Financial counselors are available at Beverly Hospital, 85 Herrick St., Beverly, to assist you in accessing he
8/10/17 - Innovus Pharma Orders its First Commercial Batch of 220,000 Units of FlutiCare
Release date- 09082017- Innovus Pharmaceuticals Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced that it ordered 220,000 units of its FlutiCare drug destined for its
8/9/17 - ELITE PHARMACEUTICALS INC /NV/ - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2016 The following discussion of our financial condition and results of operations for the three months ended June 30, 2017 and 2016 should be read in conjunction with our unaudited condensed consolidated financial statements and the notes to those statements that are included elsewhere in this report.
8/9/17 - Governor Wolf Urges President Trump to Heed Opioid Commission's Recommendations
Pennsylvania Governor Tom Wolf today urged President Donald Trump to heed the recommendations of the President's Commission on Combating Drug Addiction and the Opioid Crisis. In Pennsylvania, I have found bipartisan common ground on increasing funding for treatment, resources for health professionals, and tools for law enforcement.
8/9/17 - Innovus Pharma Orders its First Commercial Batch of 220,000 Units of FlutiCare?
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced that it ordered 220,000 units of its FlutiCare? drug destined for its projected launch
8/9/17 - Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)
Klaria AB and Purdue Pharma today announce they have entered into exclusive development and license and supply agreements for KL-00514. Craig Landau, President and CEO, Purdue Pharma. "Prescription opioid medicines remain a safe and effective treatment option for patients who are appropriately selected and monitored; however, these medicines hav
8/9/17 - MYLAN N.V. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The interim results of operations and comprehensive earnings for the three and six months ended June 30, 2017 and cash flows for the six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the full fiscal year or any other future period. Such forward-looking statements may include, without limitation, stateme
8/9/17 - OPKO Health Reports Second Quarter 2017 Business and Financial Results
Release date- 08082017- MIAMI- OPKO Health Inc., reports business and financial results for the three and six months ended June 30, 2017. Analytic and clinical validation studies of OPKO's proprietary POC diagnostic test for PSA have been completed; PMA application to the FDA is planned for 4 Q 2017. OPKO expects to begin an additional multicenter
8/9/17 - State sues maker of OxyContin [The New Hampshire Union Leader, Manchester]
Ownership: Purdue Pharma LP is a privately held company headquartered in Stamford, Conn.. CONCORD Capping a two-year probe, the Attorney General's Office sued prescription pain pill maker Purdue Pharma, charging it deceptively marketed OxyContin and other medications that led to patients getting hooked on heroin and fueling the state's opioid e
8/9/17 - SYNERGY PHARMACEUTICALS, INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with our condensed consolidated financial statements and other financial information appearing elsewhere in this quarterly report. In addition to historical information, the following discussion and other parts of this quarterly report contain forward-looking statements.
8/8/17 - Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced second quarter 2017 financial results with Net Revenues of $8.7 million, up 17% over the prior year quarter. Entered into and launched a new co-promotion agreement for Kristalose , more than doubling the numbe
8/8/17 - First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
RADICAVA, the first FDA- approved ALS treatment option in more than 20 years, has been demonstrated to slow the decline in the loss of physical function in ALS patients by 33 percent in its clinical trial. 1, 2. "It gives me great joy that RADICAVA is now available in the U.S.," said Atsushi Fujimoto, President, Mitsubishi Tanabe Pharma America. W
8/8/17 - Genentech - FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf in Erdheim Chester Disease with BRAF V600 Mutation
Release date- 07082017- South San Francisco- Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental New Drug Application and granted Priority Review for Zelboraf for Erdheim Chester disease with BRAF V600 mutation. Zelboraf was also granted Breakthrough Therapy Desi
8/8/17 - Healthcare platform will help source medicines for patients [China Daily: Africa Weekly]
Alibaba Group Holding Ltd plans to set up an online healthcare platform to help patients source medicines. The e-commerce giant announced this week that it would roll out a service under Ali Health to solve the problem of finding prescription drugs for numerous ailments. "This non-profit platform, known as the Global Drug Seeking Union, aims to he
8/8/17 - HEARING AIDS Warren says bill shows her bipartisanship Cost of devices a major impediment
Elizabeth Warren's political rivals argue she is too partisan and hasn't delivered enough for Massachusetts. During a WGBH appearance with Warren-friendly hosts Andrea Cabral and Marcela Garcia, Warren was asked to explain how she got a bill through Congress that could sharply reduce the cost of hearing aids by making them available over the counte
8/8/17 - OPKO Health Reports Second Quarter 2017 Business and Financial Results
OPKO Health, Inc., reports business and financial results for the three and six months ended June 30, 2017.. Analytic and clinical validation studies of OPKO s proprietary POC diagnostic test for PSA have been completed; PMA application to the FDA is planned for 4 Q 2017. OPKO expects to begin an additional multicenter study of its POC testost
8/8/17 - VALEANT PHARMACEUTICALS INTERNATIONAL, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Our accompanying unaudited interim Consolidated Financial Statements as of June 30, 2017 and for the three and six months ended June 30, 2017 and 2016 have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission fo
8/7/17 - FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company s supplemental New Drug Application and granted Priority Review for Zelboraf for Erdheim-Chester disease with BRAF V600 mutation. Zelboraf was also granted Breakthrough Therapy Designation by the FDA for this indication.
8/7/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 35965) - Webinar
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting by webinar to provide a status update on the process of FDA and industry discussions on an Over-the-Counter Monograph user fee program that began in July 2016.
8/7/17 - New Chronic Pain Relief Product "Venodol" Now Available for Pre-order at Venodol.com
Spotlight Innovation Inc., a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that its subsidiary Caretta Therapeutics' new over-the-counter chronic pain relief product, Venodol roll-on, is now available for pre-order in the U.S. at venodol.com. "We created Venodol to fill a need for a non-opioid alternativ
8/7/17 - TECHCARE CORP. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. Back to Table of Contents
The following plan of operation provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. Additional information concerning factors which could cause differences between forward-looking statements and future actual results is discussed under the heading "...
8/5/17 - CTA Praises Senate for Passing Over-the-Counter Hearing Aid Act
The Consumer Technology Association issued the following statement by President and Chief Executive Officer Gary Shapiro regarding the Senate's passage of the Food and Drug Administration Reauthorization Act of 2017, which includes the Over-the-Counter Hearing Aid Act:. "We applaud the Senate for passing the Over-the-Counter Hearing Aid Act, and..
8/5/17 - Senate Appropriations Committee Issues Report on Agriculture, Rural Development, FDA, Related Agencies Appropriations Bill, 2018 (Part 6 of 6)
Dietary Ingredients Guidance.The Committee encourages FDA to meet with representatives of the supplement industry as well as consumer groups and to review all comments received regarding the "Dietary Supplements: New Dietary Ingredient Notifications and Related Issues" guidance. The Committee directs the FDA to provide a report no later than 12..
8/5/17 - VANC Pharmaceuticals Closed First Tranche of Non Brokered Private Placement [T-break Tech (Middle East)]
-VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets and point-of-care technologies announces today it has closed the first tranche of the non-brokered private placement for a total of 1,326,667 units of the Company at a price of $0.15 per Unit for gross of approximately CDN $199,000
8/4/17 - AAP Statement on Senate Passage of FDA Reauthorization Act of 2017
The American Academy of Pediatrics issued the following statement by President Fernando Stein on Senate passage of the FDA Reauthorization Act:. The Academy now calls on FDA to address the exemption of drugs to treat rare pediatric diseases. The current process for FDA to update OTC monographs is cumbersome and complex, making it hard for FDA to ke
Articles(s): 1 - 25 of 112     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415